Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CombiflexOmega vs SmofKabiven in Postoperative Patients
NCT01533766Phase 3Completed
- Sponsor
- JW Life Science
- Start
- Aug 2011
- Primary completion
- Jan 2012
- Modality
- Lipid-based Nanoparticles, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Combiflex Omega in Malnutrition, sponsored by JW Life Science. Started Aug 2011; status: completed.
02
Drugs
Combiflex Omega
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT01533766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533766.